Results 271 to 280 of about 28,689 (318)

A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata. [PDF]

Cells
Gensure R, King B, Sikkink S, Mardaryev A, Goforth R.   +4 more
europepmc   +1 more source

Hyper-activation of STAT3 sustains progression of non-papillary basal-type bladder cancer via FOSL1 regulome [PDF]

, 2019
et al,, Vermi, William
core   +1 more source

Myelofibrosis: Treatment Options After Ruxolitinib Failure. [PDF]

Curr Oncol
Stuckey R, Segura Díaz A, Gómez-Casares MT.   +2 more
europepmc   +1 more source

REAL-WORLD OUTCOMES OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE TREATED WITH RUXOLITINIB. [PDF]

Blood Cell Ther
Ravindranath A, Selvarajan S, Lionel S, Devasia AJ, Korula A, N Aboobacker F, M Lakshmi K, Balasubramanian P, George B, Mathews V, Abraham A, Kulkarni U.   +11 more
europepmc   +1 more source

Novel <i>USP18</i> mutations lead to severe interferonopathy responsive to JAK inhibitor. [PDF]

Front Immunol
Sun X, Li M, Dou Y, Wang Q, Lai J, Zhu J, Zhou Q, Yu X.   +7 more
europepmc   +1 more source

The potential antitumor mechanism and clinical potential of Higd-1a in colorectal cancer. [PDF]

Sci Rep
Xu Z, Zhang H, Chen Y, Mao Y.
europepmc   +1 more source

The Evolving Role of Hematopoietic Stem Cell Transplantation in Philadelphia-like Acute Lymphoblastic Leukemia: From High-Risk Standard to Precision Strategies. [PDF]

Cancers (Basel)
Molica M, Simio C, De Fazio L, Alati C, Rossi M, Martino M.   +5 more
europepmc   +1 more source

Clinical and disease characteristics from REVEAL at time of enrollment (baseline): Prospective observational study of patients with polycythemia vera in the United States [PDF]

, 2018
Boccia, Ralph V, Colucci, Philomena, Grunwald, Michael R, Mesa, Ruben, Oh, Stephen T, Paranagama, Dilan, Parasuraman, Shreekant, Stein, Brady L   +7 more
core   +1 more source

Ruxolitinib treatment outcomes in acute graft-versus-host disease (aGvHD) in a real-world setting in Finland. [PDF]

Ann Hematol
Martelin E, Kuikka A, Rajala H, Ruohonen T, Mönkkönen H, Vikkula J, Uusi-Rauva K, Salmenniemi U, Itälä-Remes M.   +8 more
europepmc   +1 more source

Ruxolitinib in adult dermatomyositis with anti-TIF1γ antibody: a case report and literature review. [PDF]

Front Immunol
Jing X, Min W, Xia L, Shanshan L.
europepmc   +1 more source